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Point of view 
 
Key-points 
1. Patient with recent history of dry cough, fever and breathlessness 
(influenza-like or severe acute respiratory illness) without alternative 
explanation/diagnosis needs to be managed as COVID-19 unless 
proved otherwise.  
2. Suspected COVID-19 patient having fever and recent loss of taste and 
smell be tested for COVID-19.  
3. Patient with severe acute respiratory illness of unknown aetiology be 
tested for COVID-19. 
4. Patient with bilateral consolidation on chest X-ray or ground glass 
appearance on chest CT or interstitial oedema on chest ultrasound (not 
fully explained by volume overload) be tested for COVID-19 in 
moderate to high risk communities/countries.  
5. Suspected COVID-19 patients with lymphopenia, high ESR or rise in C-
reactive protein and suspected of viral fevers be tested for COVID-19. 
6. Screening of pregnant women for COVID-19 with rapid testing 
preferably with Elisa in moderate to high risk communities/countries. 
7. Screening with rapid testing preferably with Elisa prior to invasive 
interventions, including operations, in moderate to high risk 
communities/countries.  
8. Limit the exposure of hospital staff who are susceptible to develop 
severe complications of COVID-19. 
9. Hospitals provide PPE to staff depending upon exposure as per 
international/national/local guidelines. 
10. Hospitals implement infection prevention control measures 
meticulously in context of COVID-19. 
 
The COVID-19 is an acute, highly contagious infectious disease caused by 
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily 
involving respiratory system. World Health Organization (WHO) declared 
COVID-19 a global pandemic on 11 March 2020.1 It is primarily transmitted 
through respiratory droplets. When an infected person coughs, sneezes, 
or talks, they can infect person/s who is/are in direct contact or within 1.5 
meters. Also, infection can occur if someone touches contaminated 
surfaces/articles and then touches eyes, nose, or mouth.2 
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Clinical course ranges from asymptomatic to 
very mild disease, and may progress to severe 
disease with pneumonia and some patients 
become critical leading to life-threatening 
complications such as acute respiratory 
distress syndrome (ARDS), shock, and multi 
organ dysfunction syndrome (MODS). Around 
80%, 15% and 5% of patients have mild, 
moderate-severe and critical disease 
respectively. Critical disease predominantly 
affects advanced-age population, and patients 
with comorbidities.3   
 
The most common symptoms are fever, 
fatigue and dry cough; common symptoms 
shortness of breath (an early indicator of rapid 
deterioration), loss of smell (sometimes the 
only symptom) and/or taste, loss of appetite 
and myalgia; and less common symptoms 
diarrhea, abdominal pain, sputum production, 
rhinitis, sore throat, headache. The triad of 
fever, cough, and dyspnea is seen in around 15% 
patients. Majority of symptomatic patients 
present with pulmonary and constitutional 
symptoms while some may have extra-
pulmonary manifestations such as encephalitis, 
Guillain-Barré Syndrome, diarrhea, loss of 
smell/taste, acute kidney injury (AKI), 
hepatopathy, conjunctivitis, diabetes and 
hyperglycemia among people without prior 
diabetes.4 
 
White blood cell count varies from leukopenia 
to leukocytosis; lymphopenia is most common. 
Thrombocytopenia, increased lactate 
dehydrogenase (LDH) and ferritin are common, 
but aminotransferase are also elevated.5  
 
Chest radiographs may be normal in early-
stage or in mild disease; common findings are 
consolidation and ground glass opacities, with 
bilateral, peripheral, and lower zone 
distributions. Interstitial edema is detected on 
chest ultrasound. The most common CT scan 
findings are ground-glass opacification with or 
without consolidation; findings consistent with 
viral pneumonia.5  
 
Laboratory features associated with worse 
outcome are lymphopenia, elevated liver 
enzymes, LDH, C-reactive protein (CRP), 
ferritin, erythrocyte sedimentation rate (ESR), 
D-dimer (>1mcg/mL), prothrombin time (PT), 
troponin, creatine phosphokinase (CPK), and 
creatinine).6 
 
There is no specific therapy recommended for 
COVID-19, and no vaccine is currently available. 
But different drugs in various combinations 
have been used in different hospitals in 
different countries. Management consists of 
supportive care. Home management is more 
appropriate for patients having mild disease, 
and adequately isolated outpatient setting. A 
minority of patients need critical care including 
mechanical ventilation. For moderate-severe 
cases indoor hospital care and possibly 
intensive care management including oxygen 
therapy is required.7 
 
Currently, therapeutic strategies to deal with  
COVID-19 are only supportive and prevention 
aimed at reducing transmission in community 
(physical distancing, good health hygiene 
practices including respiratory hygiene, hand 
washing, protecting eyes), testing suspects, 
isolating confirmed cases and quarantining 
contacts. Furthermore, peoples have to avoid 
crowds and limit contacts. Physical distancing 
is advocated in locations where community 
transmission is highly likely and use of face 
masks are advised in public.8 
 
The COVID-19 is confirmed with real-time 
polymerase-chain-reaction (RT-PCR) and 
patients are declared as recovered after two 
consecutive RT-PCR tests become negative. 
There are reports of positive RT-PCR in some 
patients previously declared recovered. It’s not 
known whether they got re-infected or there is 
reactivation of the virus. At least 110 people in 
South Korea tested positive for COVID-19 after 
having been thought to be completely 
recovered.9 
 
Use of universal COVID-19 testing in pregnant 
women presenting for delivery revealed that 
currently, in the pandemic New York City, most 
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There is community transmission in most 
countries. The possibility of second wave of 
transmission cannot be ruled out at this point-
in-time. Singapore’s coronavirus caseload 
increased over two-fold in past few days, with 
more than 8,000 confirmed cases as of April 20, 
2020.11 
 
The WHO recommends that standard, contact, 
and droplet precautions (gown, gloves, 
medical mask and eye protection with goggle 
or face shield) be used for all personnel 
entering room of a patient with suspected or 
confirmed COVID-19. Healthcare workers are 
first line warriors and are at extremely high risk 
of contracting the infection. Thousands of 
healthcare workers contracted COVID-19 
infection and many of them lost their lives. 
Without secure supply-chains of personal 
protective equipment (PPE), risk to healthcare 
workers around the world is real. Ability to 
care for suspected or confirmed COVID-19 
patients depends on well-being of the 
healthcare workforce (physical and emotional). 
Putting workers’ well-being first, creates 
positive environment for quality care despite 
the circumstances.12 
 
It is obvious from the situation that we have to 
live with COVID-19 for months and possibly 
years to come. Hence, there is a need to 
change policy at hospital level so as to utilize 
maximum capacity of healthcare workforce 
without harming them. It is suggested that – 
 
I. Possibility of COVID-19 may be considered 
in patients with-  
a. Recent history of dry cough, fever and 
breathlessness (influenza-like or severe 
acute respiratory illness). 
b. Fever with recent loss of taste/smell.  
c. Severe acute respiratory illness of 
unknown aetiology.   
d. Bilateral consolidation on chest X-ray or 
ground glass appearance on chest CT or 
interstitial oedema on chest ultrasound 
(not fully explained by volume 
overload).  
e. Lymphopenia, high ESR or rise in CRP 
and suspected of viral fevers.   
 
II. Universal screening with rapid testing with 
Elisa (or testing with PCR if possible) for 
some categories of people- like 
a. Pregnant women in moderate to high 
risk communities/countries. 
b. Patient requiring invasive procedure 
including operation in moderate to high 
risk communities/countries.  
c. Patient with immunocompromised 
status or with chronic diseases in 
moderate to high risk 
communities/countries.   
 
III. Prevention and control of infection by 
mandatory- 
a. Provision of PPE to staff as per 
International/National/Local Guidelines. 
b. Implementation of practice of health 
hygiene by staff.  
c. Implementation of meticulous infection 
prevention and control measures. 
d. Limiting the exposure of staff who are 
susceptible to severe complications of 
COVID-19, such as staff older than 60 
years, having chronic diseases like 
diabetes mellitus, immunocompromised 
or pregnant. They should avoid contact 
with suspected or confirmed case.   
e. Limiting visitors to hospital as to 
maintain physical distancing and spread 
of infections.    
f. Instruction to patients to wear face 
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